Detalles de la búsqueda
1.
Circulating tumour cells and PD-L1-positive small extracellular vesicles: the liquid biopsy combination for prognostic information in patients with metastatic non-small cell lung cancer.
Br J Cancer
; 130(1): 63-72, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37973956
2.
Early detection of pancreatic cancer by liquid biopsy "PANLIPSY": a french nation-wide study project.
BMC Cancer
; 24(1): 709, 2024 Jun 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38853244
3.
Detection of Circulating Tumor Cells in Cerebrospinal Fluid of Patients with Suspected Breast Cancer Leptomeningeal Metastases: A Prospective Study.
Clin Chem
; 68(10): 1311-1322, 2022 10 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35953885
4.
Selective treatment pressure in colon cancer drives the molecular profile of resistant circulating tumor cell clones.
Mol Cancer
; 20(1): 30, 2021 02 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33557844
5.
Programmed Cell Death Ligand 1-Expressing Circulating Tumor Cells: A New Prognostic Biomarker in Non-Small Cell Lung Cancer.
Clin Chem
; 67(11): 1503-1512, 2021 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34355741
6.
Proficiency Testing to Assess Technical Performance for CTC-Processing and Detection Methods in CANCER-ID.
Clin Chem
; 67(4): 631-641, 2021 03 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-33491069
7.
Clinical Correlations of Programmed Cell Death Ligand 1 Status in Liquid and Standard Biopsies in Breast Cancer.
Clin Chem
; 66(8): 1093-1101, 2020 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32712650
8.
Tumor-Associated Release of Prostatic Cells into the Blood after Transrectal Ultrasound-Guided Biopsy in Patients with Histologically Confirmed Prostate Cancer.
Clin Chem
; 66(1): 161-168, 2020 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31601564
9.
Circulating Tumor Cells as a Prognostic Factor in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: The CIRCUTEC Prospective Study.
Clin Chem
; 65(10): 1267-1275, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31387885
10.
Molecular Portrait of Metastasis-Competent Circulating Tumor Cells in Colon Cancer Reveals the Crucial Role of Genes Regulating Energy Metabolism and DNA Repair.
Clin Chem
; 63(3): 700-713, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28007957
11.
Prognostic relevance of viable circulating tumor cells detected by EPISPOT in metastatic breast cancer patients.
Clin Chem
; 60(1): 214-21, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24255082
12.
Circulating Tumor Cell Detection by Liquid Biopsy during Early-Stage Endometrial Cancer Surgery: A Pilot Study.
Biomolecules
; 13(3)2023 02 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-36979364
13.
Epigenomic reprogramming of therapy-resistant circulating tumor cells in colon cancer.
Front Cell Dev Biol
; 11: 1291179, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38188020
14.
Inhibition of Wnt Signaling in Colon Cancer Cells via an Oral Drug that Facilitates TNIK Degradation.
Mol Cancer Ther
; 22(1): 25-36, 2023 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36302395
15.
In vitro cross-talk between metastasis-competent circulating tumor cells and platelets in colon cancer: a malicious association during the harsh journey in the blood.
Front Cell Dev Biol
; 11: 1209846, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37601099
16.
Epigenomic analysis reveals a unique DNA methylation program of metastasis-competent circulating tumor cells in colorectal cancer.
Sci Rep
; 13(1): 15401, 2023 09 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37717096
17.
First evidence of AXL expression on circulating tumor cells in metastatic breast cancer patients: A proof-of-concept study.
Cancer Med
; 2023 Dec 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-38132919
18.
Epithelial-to-Mesenchymal Plasticity in Circulating Tumor Cell Lines Sequentially Derived from a Patient with Colorectal Cancer.
Cancers (Basel)
; 13(21)2021 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34771571
19.
Clinical Relevance of Viable Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer: The COLOSPOT Prospective Study.
Cancers (Basel)
; 13(12)2021 Jun 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-34199250
20.
Efficacy of Circulating Tumor Cell Count-Driven vs Clinician-Driven First-line Therapy Choice in Hormone Receptor-Positive, ERBB2-Negative Metastatic Breast Cancer: The STIC CTC Randomized Clinical Trial.
JAMA Oncol
; 7(1): 34-41, 2021 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33151266